Urovant Sciences Ltd Ret. on equity
What is the Ret. on equity of Urovant Sciences Ltd?
The Ret. on equity of Urovant Sciences Ltd is 163.05%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Urovant Sciences Ltd
Companies with ret. on equity similar to Urovant Sciences Ltd
- Tui Ag has Ret. on equity of 161.79%
- TUI AG has Ret. on equity of 161.79%
- Austral Resources Australia has Ret. on equity of 162.44%
- Splunk has Ret. on equity of 162.45%
- Splunk has Ret. on equity of 162.45%
- Rite Aid has Ret. on equity of 162.53%
- Urovant Sciences Ltd has Ret. on equity of 163.05%
- Jack Nathan Medical has Ret. on equity of 163.35%
- DCM has Ret. on equity of 164.09%
- Trend Innovations has Ret. on equity of 164.43%
- North Mining Shares has Ret. on equity of 164.47%
- American Resources has Ret. on equity of 165.00%
- Avrupa Minerals has Ret. on equity of 165.47%